Jasper Therapeutics, Inc. (JSPR) vs DataMEDS AI, Inc. (MEDS)
A side-by-side comparison of Jasper Therapeutics, Inc. and DataMEDS AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
JSPR
Jasper Therapeutics, Inc.
$0.55HealthcareDelayed quote: Oct 6, 2026, 3:04 PM EDT
MEDS
DataMEDS AI, Inc.
$3.14HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — JSPR vs MEDS
growth of $100 · dividends reinvested · last 7yJSPR -99.4% (-51.8%/yr)MEDS -97.0% (-39.5%/yr)MEDS compounded faster over this window
JSPR MEDS
JSPR vs MEDS: by the numbers
- •JSPR is the larger company ($9M vs $8M market cap).
- •Both run net losses; JSPR's is the smaller (0.00% vs -1100.30% net margin).
Metrics side by side
Valuation
| Metric | JSPR | MEDS |
|---|---|---|
| P/S ratio | N/A | 1.03 |
| P/B ratio | 6.33 | N/A |
Profitability
| Metric | JSPR | MEDS |
|---|---|---|
| Gross margin | 0.00% | -41.30% |
| Operating margin | 0.00% | -347.91% |
| Net margin | 0.00% | -1100.30% |
| ROE | -2248.48% | N/A |
| ROIC | -1394.09% | -439.90% |
Growth (annualized)
| Metric | JSPR | MEDS |
|---|---|---|
| Total return CAGR (5Y) | -62.51% | -45.88% |
Frequently asked
- How have JSPR and MEDS total returns compared?
- Over the past 5 years, JSPR delivered -62.51% and MEDS delivered -45.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.